mRNA |
LRRK2-IN-1 |
CTRPv2 |
pan-cancer |
AAC |
0.061 |
0.1 |
mRNA |
ISOX:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.057 |
0.1 |
mRNA |
RG-108 |
CTRPv2 |
pan-cancer |
AAC |
0.059 |
0.1 |
mRNA |
TGX221 |
GDSC1000 |
pan-cancer |
AAC |
-0.076 |
0.1 |
mRNA |
BRD-K30019337 |
CTRPv2 |
pan-cancer |
AAC |
-0.12 |
0.1 |
mRNA |
sirolimus:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.055 |
0.1 |
mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.066 |
0.1 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.05 |
0.1 |
mRNA |
EX-527 |
GDSC1000 |
pan-cancer |
AAC |
0.055 |
0.1 |
mRNA |
semagacestat |
CTRPv2 |
pan-cancer |
AAC |
-0.059 |
0.1 |